APPLICATION OF LIMITING MARGINAL ABATEMENT COSTS IN OPTIMISED STRATEGIES TO REDUCE ACIDIFICATION AND EUTROPHICATION IN EUROPE: ILLUSTRATIONS USING THE ABATEMENT STRATEGIES ASSESSMENT MODEL (ASAM)

2000 ◽  
Vol 02 (01) ◽  
pp. 119-166 ◽  
Author(s):  
RACHEL F. WARREN ◽  
HELEN M. APSIMON

The Convention on Long-Range Transboundary Air Pollution has led to the setting up of international protocols to reduce emissions of oxides of sulphur and nitrogen, ammonia, and volatile organic compounds (VOCs). Policy makers have made use of optimised abatement strategies derived by integrated assessment models (IAMs) which cost-effectively reduce acidification, eutrophication and tropospheric ozone. IAMs use information on costs of potential emission abatement options in individual countries. This paper explores the implications of limiting the abatement options in IAMs to those with moderate marginal costs. Three methods of applying this constraint to the optimisation are described. All methods indicate a loss of cost-effectiveness, this being most severe when marginal costs are constrained and environmental constraints are not compromised. However, when the overall investment level is capped and the strategy re-optimised taking into account marginal cost limitation whilst allowing violation of the original environmental targets, the loss of cost-effectiveness is less severe. For all three methods, significant changes occur in patterns of country expenditures and environmental protection, which tends to decrease significantly in those areas most difficult to protect. However, the re-optimisation method does provide the opportunity for "compensating" improvements to be achieved in other areas which are easier to protect. The choice of marginal cost limits strongly affects the extent and nature of these changes, as does the nature of the original optimised strategy.

Author(s):  
Nadine T. Hillock ◽  
Tracy L. Merlin ◽  
Jonathan Karnon ◽  
John Turnidge ◽  
Jaklin Eliott

Abstract Background The frameworks used by Health Technology Assessment (HTA) agencies for value assessment of medicines aim to optimize healthcare resource allocation. However, they may not be effective at capturing the value of antimicrobial drugs. Objectives To analyze stakeholder perceptions regarding how antimicrobials are assessed for value for reimbursement purposes and how the Australian HTA framework accommodates the unique attributes of antimicrobials in cost-effectiveness evaluation. Methods Eighteen individuals representing the pharmaceutical industry or policy-makers were interviewed. Interviews were transcribed verbatim, coded, and thematically analyzed. Results Key emergent themes were that reimbursement decision-making should consider the antibiotic spectrum when assessing value, risk of shortages, the impact of procurement processes on low-priced comparators, and the need for methodological transparency when antimicrobials are incorporated into the economic evaluation of other treatments. Conclusions Participants agreed that the current HTA framework for antimicrobial value assessment is inadequate to properly inform funding decisions, as the contemporary definition of cost-effectiveness fails to explicitly incorporate the risk of future resistance. Policy-makers were uncertain about how to incorporate future resistance into economic evaluations without a systematic method to capture costs avoided due to good stewardship. Lacking financial reward for the benefits of narrower-spectrum antimicrobials, companies will likely focus on developing broad-spectrum agents with wider potential use. The perceived risks of shortages have influenced the funding of generic antimicrobials in Australia, with policy-makers suggesting a willingness to pay more for assured supply. Although antibiotics often underpin the effectiveness of other medicines, it is unclear how this is incorporated into economic models.


2000 ◽  
Vol 89 (S 01) ◽  
pp. S23-S26 ◽  
Author(s):  
R van Haselen

AbstractObjective: The practical implementation of a staged, multifaceted research agenda for the economic evaluation of complementary medicine (CM) at the Royal London Homoeopathic Hospital (RLHH).Method: The relative importance of economic evaluation as an evidence base of CM was assessed via a survey conducted with purchasers (n=481). The marginal costs of providing complementary care for patients with rheumatoid arthritis were calculated. The use, and changes in the use, of conventional medicines for patients’ main complaints were established retrospectively (n=499) and prospectively (n=70). Health-related quality of life (patient utility) of newly referred patients was assessed with the EQ-5D (EuroQol) instrument (n=70) on a 100 mm (0=worst, 100=best) scale.Results: Economic evaluation was rated ‘important’ as an evidence base, after safety and RCT data (‘very important’). Consultation time (doctors and dietician) contributed 29% of the total costs of treating rheumatoid arthritis. The retrospective survey showed that many patients on conventional medication were able to stop (29%) or reduce (32%) intake in the course of treatment. The median (quartiles) health state of newly referred patients was 70 mm (50,78) in men and 60 mm (36,73) in women. Some results of an interim analysis of 6 months follow-up data are reported.Conclusions: Economic evaluation of CM is becoming increasingly important and should take place by using a multifaceted, staged approach. Before embarking on randomised trials, observational data on cost, effectiveness and utility should be collected. The cost-effectiveness of CM appears to be most sensitive to the duration of the consultation.


1999 ◽  
Vol 89 (3) ◽  
pp. 585-604 ◽  
Author(s):  
Stephen W Salant ◽  
Greg Shaffer

Oligopoly models where prior actions by firms affect subsequent marginal costs have been useful in illuminating policy debates in areas such as antitrust regulation, environmental protection, and international competition. We discuss properties of such models when a Cournot equilibrium occurs at the second stage. Aggregate production costs strictly decline with no change in gross revenue or gross consumer surplus if the prior actions strictly increase the variance of marginal costs without changing the marginal-cost sum. Therefore, unless the cost of inducing second-stage asymmetry more than offsets this reduction in production costs, the private and social optima are asymmetric. (JEL D43, L13, L40)


2004 ◽  
Vol 92 (09) ◽  
pp. 590-597 ◽  
Author(s):  
Fredric Chan ◽  
Raymond Wong ◽  
Gregory Cheng ◽  
Joyce You

SummaryVariant cytochrome P450 (CYP) 2C9 genotypes are associated with low maintenance dose requirement of warfarin therapy and increased risk of major bleeding events. The objective of the present study was to evaluate the potential clinical and economic outcomes of using CYP2C9 genotype data to guide the management of anticoagulation therapy and to identify influential factors affecting the cost-effectiveness of this treatment scheme. A decision tree was designed to simulate, over 12 months, the clinical and economic outcomes of patients newly started on warfarin associated with two alternatives: (1) no genotyping (non-genotyped group) and (2) CYP2C9 genotyping prior to initiation of warfarin therapy (genotyped group). Nongenotyped group patients would receive standard care of an anticoagulation clinic (AC). In the genotyped group, patients with at least one variant CYP2C9 allele would receive intensified anticoagulation service. Most of the clinical probabilities were derived from literature. The direct medical costs were estimated from the Diagnosis-Related Group charges and from literature. The total number of events and the direct medical cost per 100 patient-years in the genotyped and non-genotyped groups were 9.58 and USD155,700, and, 10.48 and USD 150,500, respectively. The marginal cost per additional major bleeding averted in the genotyped group was USD 5,778. The model was sensitive to the variation of the cost and reduction of bleeding rate in the intensified anticoagulation service. In conclusion, the pharmacogenetics-oriented management of warfarin therapy is potentially more effective in preventing bleeding with a marginal cost. The cost-effectiveness of this treatment scheme depends on the relative cost and effectiveness of a pharmacogenetics-oriented intensified anticoagulation service comparing to the standard AC care.


Author(s):  
Noor Saazai Mat Saad ◽  
Ramiaida Darmi ◽  
Suraini Mohd Ali ◽  
Nurkhamimi Zainuddin ◽  
Normazla Ahmad Mahir ◽  
...  

Teaching practicum is an integral feature of any education-based program. Teaching competency, expertise, and quality are developed and refined during the practicum, as a form to assess these teachers to-be. Traditionally, it is conducted with the supervisors visiting the supervisees' schools for observations of the teaching and learning activities in class. Tapping on the advent of technology, researchers from USIM have innovated this practice through an online practicum supervision tool called electronic practicum assessment model (e-PRASMO). After undergoing two rounds of research and improvisation, e-PRASMO embodies the strengths of its innovation and practicality: cost effectiveness, stress-free environment, flexibility, technological enhancement, reflexivity, and accessibility. It also espouses the framework of the 3 P's model by Biggs, showing the amalgamation of both the online and traditional teaching practicum activities. With more uniqueness offered by e-PRASMO, it becomes a revolutionized innovation for practicum method and assessment aligned with the current era.


2019 ◽  
Vol 19 (1) ◽  
pp. 4-11 ◽  
Author(s):  
Jen Iris Allan

After a decade of negotiation, countries adopted a new, legally binding agreement on climate change. Excitement for a new era in the climate regime is palpable among pundits and policy makers alike. But such enthusiasm largely overlooks that most of the Paris Agreement’s provisions represent continuity with existing climate policy, not a break with the past. This forum argues that the Paris Agreement is a dangerous form of incrementalism in two ways. First, it repackages existing rules that have already proven inadequate to reduce emissions and improve resilience. Second, state and nonstate actors celebrate the Agreement as a solution, conferring legitimacy on its rules; I suggest that, beyond the strong desire to avoid failure, developing countries and nongovernmental organizations accepted the Paris Agreement to secure the participation of the United States and to uphold previous agreements. Given the reification of existing rules, the ratchet-up mechanism and nonstate actors offer the last remaining hopes in global efforts to catalyze climate action on a scale necessary to safeguard the climate.


2002 ◽  
Vol 2 ◽  
pp. 1254-1266
Author(s):  
Ekko van Ierland ◽  
Corjan Brink ◽  
Leen Hordijk ◽  
Carolien Kroeze

Environmental economics deals with the optimal allocation of production factors and correcting market failure in protecting the environment. Market failure occurs because of externalities, common property resources, and public goods. Environmental policy instruments include direct regulation, taxes/subsidies, tradable permits, deposit systems, voluntary agreements, and persuasion.Environmental policies usually focus on one pollutant or environmental issue but may have substantial impacts on other emissions and environmental problems. Neglecting these impacts will result in suboptimal policies. We present an integrated optimisation model for determining cost-effective strategies to simultaneously reduce emissions of several pollutants from several sources, allowing for interrelations between sources and abatement options. Our integrated approach in regard to acidifying compounds and greenhouse gases will be able to provide cost-effective policy options that will result in lower overall abatement costs.This paper shows that efficient emission reduction can be calculated, but we argue that, for transboundary air pollution and climate change, it is difficult to implement the socially optimal solution because strong incentives exist for “free-riding”. In order to implement efficient policies, international environmental agree-ments like the Gothenburg or the Kyoto Protocol are necessary to establish stable coalitions. The stability of these agreements depends on the distribution of costs and benefits over countries and on the redistribution of the gains of cooperation.


2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Nathan E. Hultman ◽  
Leon Clarke ◽  
Carla Frisch ◽  
Kevin Kennedy ◽  
Haewon McJeon ◽  
...  

Abstract Approaches that root national climate strategies in local actions will be essential for all countries as they develop new nationally determined contributions under the Paris Agreement. The potential impact of climate action from non-national actors in delivering higher global ambition is significant. Sub-national action in the United States provides a test for how such actions can accelerate emissions reductions. We aggregated U.S. state, city, and business commitments within an integrated assessment model to assess how a national climate strategy can be built upon non-state actions. We find that existing commitments alone could reduce emissions 25% below 2005 levels by 2030, and that enhancing actions by these actors could reduce emissions up to 37%. We show how these actions can provide a stepped-up basis for additional federal action to reduce emissions by 49%—consistent with 1.5 °C. Our analysis demonstrates sub-national actions can lead to substantial reductions and support increased national action.


1999 ◽  
Vol 89 (4) ◽  
pp. 805-826 ◽  
Author(s):  
Catherine D Wolfram

This article presents an empirical study of market power in the British electricity industry. Estimates of price-cost markups are derived using direct measures of marginal cost and several approaches that do not rely on cost data. Since two suppliers facing inelastic demand dominate the industry, most oligopoly models predict prices substantially above marginal costs. All estimates indicate that prices, while higher than marginal costs, are not nearly as high as most theoretical models predict. Regulatory constraints, the threat of entry, and financial contracts between the suppliers and their customers are considered as possible explanations for the observed price levels. (JEL L13, L94)


2020 ◽  
Vol 12 (10) ◽  
pp. 4082 ◽  
Author(s):  
Tom Assmann ◽  
Sebastian Lang ◽  
Florian Müller ◽  
Michael Schenk

Mitigating climate change and improving urban livability is prompting cities to improve sustainability of urban transportation and logistics. Cargo bikes, in combination with urban transshipment points, are gaining momentum as a green last mile alternative. Although a wide body of research proves their viability in dense urban areas, knowledge about planning urban transshipment points is very limited. This also entails the siting of such facilities and the assessment of effects on emissions. This study therefore presents a first quantitative scenario-based model that assesses the impacts on a district. It examines different strategies for siting urban transshipment points in a single district and its effect on traffic, the carbon footprint, and air quality to give strategic insights where to create candidate locations for such facilities. Our result contributes to knowledge of planning urban transshipment facilities and assessing the impact of different configurations. The findings demonstrated that the use of cargo bikes to make courier, express, and parcel (CEP) deliveries in urban districts could reduce greenhouse gas (GHG), particulate matter (PM10), and nitrogen oxides (NOx) emissions significantly. However, the choice of vehicles completing inbound and outbound processes and the strategies for siting urban transshipment points display widely differing and even conflicting potential to reduce emissions.


Sign in / Sign up

Export Citation Format

Share Document